BiliBuddy vs Red Book®

BiliBuddy supports clinicians assessing neonatal jaundice in infants born at 35 weeks of gestation or later. Use Quick Check to compare a total serum bilirubin reading with American Academy of Pediatrics (AAP) 2022 phototherapy, escalation-of-care, and exchange-transfusion thresholds. Enter age in hours, gestation, and additional neurotoxicity risk factors. View the result and threshold charts in mg/dL or µmol/L. Track infants locally to review reading history, plot trends, and calculate the rate of rise. A date-and-time calculator helps determine age at measurement. Share a text result summary using the device's share sheet. The 2022 guideline is selected by default. An optional legacy AAP 2004 pathway is available in Settings, with its supported chart range clearly identified. Reference material and links to source guidelines are included. Clinical entries are stored on the device. Usage analytics is optional and off by default. Advertising and crash diagnostics use third-party services described in the in-app Privacy Notice. An in-app purchase removes ads, and Restore Purchases restores an eligible prior purchase. For clinician use. BiliBuddy does not replace clinical judgment, clinical assessment, or consultation of the source guideline. It is not an electronic health record. Do not use outside the supported age and gestation ranges.

** The Red Book is the foundational resource on pediatric infectious disease** Featuring content from the latest edition, the Red Book: 2024–2027 Report of the Committee on Infectious Diseases from the American Academy of Pediatrics (AAP) provides the most up-to-date information on a wide variety of infectious diseases that physicians encounter in children. Written and edited by leading experts in the field, along with contributions from the CDC, the FDA, and hundreds of other professionals, this resource stands as the most authoritative and comprehensive available. The Red Book features: * Immunization Schedules - Recommended immunization and catch-up schedules for infants, children, adolescents, and young adults. * Vaccine Status Table - Current information about recently submitted, licensed, and recommended vaccines and biologics, including status of the FDA licensure process and related AAP/CDC recommendations. * Influenza Resources - A comprehensive collection of information on influenza, serving as a centralized reference for vaccine guidance, prevention, treatment, payment policies, news, and other relevant details for infants, children, adolescents, and young adults. * Standardized approaches to disease prevention through immunizations, antimicrobial prophylaxis, and infection-control practices have been updated throughout the Red Book. * Two new chapters on Covid-19 and Mpox have been added. * The System-Based Treatment Table has been reordered so that the grouped recommendations by body system are more easily and quickly accessed. * Greatly expanded tables, figures and algorithms enable quick access to essential information. * The Breastfeeding and Human Milk chapter was updated to align with information from the latest AAP policy statement on breastfeeding. * The listing of Codes for Commonly Administered Pediatric Vaccines, Toxoids, and Immune Globulins has been expanded. * Reference to evidence-based policy recommendations have been updated throughout the Red Book. Unbound Medicine Features: * Highlighting and note-taking within entries * “Favorites” for bookmarking important topics * Enhanced Search to find topics quickly * Prime PubMed links to the primary literature Author: Committee on Infectious Diseases Publisher: American Academy of Pediatrics Editor: David W. Kimberlin, MD, FAAP; Associate Editors: Ritu Banerjee, MD, PhD, FAAP, Elizabeth D. Barnett, MD, FAAP; Ruth Lynfield, MD, FAAP; and Mark H. Sawyer, MD, FAAP Powered By: Unbound Medicine Unbound Medicine Privacy Policy: https://www.unboundmedicine.com/privacy Unbound Medicine Terms of Use: https://www.unboundmedicine.com/end_user_license_agreement